Vertex Pharmaceuticals (VRTX) EBT (2009 - 2026)

Vertex Pharmaceuticals (VRTX) posted quarterly EBT of $1.3 billion for Q1 2026, up 71.54% year-over-year from $730.4 million in Q1 2025, and down 5.87% on a QoQ basis from $1.3 billion in Q4 2025.

Vertex Pharmaceuticals (VRTX) EBT (2009 - 2026) Analysis & Trends

Vertex Pharmaceuticals (VRTX) has reported EBT for 18 consecutive years, with $1.3 billion the latest figure, recorded in Q1 2026.

  • In Q1 2026, EBT rose 71.54% year-over-year to $1.3 billion; the TTM figure through Mar 2026 stood at $5.2 billion (up 1820.75% YoY), while the FY2025 annual figure was $4.6 billion, up 1768.49% from the prior year.
  • EBT came in at $1.3 billion for Q1 2026 at Vertex Pharmaceuticals, down from $1.3 billion in the prior quarter.
  • The five-year high for EBT was $1.3 billion in Q4 2025, with the low at -$3.4 billion in Q2 2024.
  • Average EBT over 5 years is $868.0 million, with a median of $1.2 billion recorded in 2023.
  • Across the five-year window, EBT surged 2417.65% in 2022 and tumbled 391.97% in 2024, its largest moves.
  • Year by year, EBT stood at $1.1 billion in 2022, then gained by 6.58% to $1.1 billion in 2023, then fell by 0.97% to $1.1 billion in 2024, then grew by 17.11% to $1.3 billion in 2025, then decreased by 5.87% to $1.3 billion in 2026.
  • According to Business Quant data, EBT over the past three periods registered $1.3 billion, $1.3 billion, and $1.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Genmab A 276,399.99 Bn 276,398.47 Bn 831.00 Mn 74.00 Mn
2 Akari Therapeutics 1,217.26 Bn 1,217.26 Bn - -15.31 Mn
3 BeOne Medicines 419.38 Bn 414.59 Bn 1.35 Bn 259.22 Mn
4 Vertex Pharmaceuticals 126.54 Bn 119.30 Bn 2.59 Bn 1.25 Bn
5 Pharming 110.17 Bn 110.12 Bn 65.80 Mn -4.91 Mn
6 Regeneron Pharmaceuticals 64.97 Bn 56.22 Bn 3.31 Bn 831.20 Mn
7 Argenx Se 56.44 Bn 56.44 Bn 1.18 Bn 438.00 Mn
8 Alnylam Pharmaceuticals 40.09 Bn 37.08 Bn 959.66 Mn 221.65 Mn
9 Revolution Medicines 37.15 Bn 37.15 Bn - -453.82 Mn
10 Moderna 28.64 Bn 23.43 Bn -566.00 Mn -1.33 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.25 Bn
Dec 31, 2025 1.33 Bn
Sep 30, 2025 1.30 Bn
Jun 30, 2025 1.28 Bn
Mar 31, 2025 730.40 Mn
Dec 31, 2024 1.14 Bn
Sep 30, 2024 1.22 Bn
Jun 30, 2024 -3.39 Bn
Mar 31, 2024 1.28 Bn
Dec 31, 2023 1.15 Bn
Sep 30, 2023 1.18 Bn
Jun 30, 2023 1.16 Bn
Mar 31, 2023 891.50 Mn
Dec 31, 2022 1.08 Bn
Sep 30, 2022 1.18 Bn
Jun 30, 2022 1.02 Bn
Mar 31, 2022 954.80 Mn
Dec 31, 2021 870.90 Mn
Sep 30, 2021 1.08 Bn
Jun 30, 2021 -44.20 Mn